Insight Molecular Diagnostics Inc (IMDX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IMDX Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Insight Molecular Diagnostics Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent17.76
Cash & Short-term Investments17.00
Accounts receivable0.19
Inventories0.21
Other Current Assets0.73
Prepaid Expense And Other Assets Current1.66
Total Current Assets20.54
Equipment/Property/Plant Net6.00
Intangible Assets0.00
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent2.90
Total Assets29.44
Liabilities
Accounts Payable, Current AC1.87
Accrued Liabilities, Current AC1.90
Other Liabilities, Current4.21
Taxes Payable1.60
Business Combination, Contingent Consideration, Liability, Current BU0.71
Total Current Liabilities10.29
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent40.46
Total Liabilities50.74
Stockholders' Equity
Common Stock Value394.95
Retained Earnings / Accumulated Deficit-416.31
Accumulated Other Comprehensive Income0.07
Other Equity0.07
Common Stockholder's Equity-21.30
Total Stockholder's Equity-21.30
Liabilities & Stockholder's Equity29.44
4 historic quarters locked

Sign in to unlock the full Insight Molecular Diagnostics Inc balance sheet history.

About Insight Molecular Diagnostics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001642380-26-000011

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.